Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/erythroderme-psoriasis-nach-covid-19-erkrankung-2FkepmFajl
References (53)
-
GK Kim (2010)
32J Clin Aesthet Dermatol, 3
-
Ö Kutlu (2020)
e13509Dermatol Ther, 33
-
P. Munguía-Calzada, M. Drake-Monfort, S. Armesto, L. Cura, A. López-Sundh, M. González‐López (2020)
Psoriasis flare after influenza vaccination in Covid‐19 era: A report of four cases from a single centerDermatologic Therapy, 34
-
R. Ozaras, A. Berk, Dilek Ucar, H. Duman, Fatma Kaya, Huseyin Mutlu (2020)
Covid‐19 and exacerbation of psoriasisDermatologic Therapy, 33
-
Florence Am (2020)
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patientsAnnals of the Rheumatic Diseases, 80
-
Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID- (2021)
//dgrh.de/Start/Wissenschaft/Forschung/COVID-19.html. Zugegriffen: 13. Dez. 2021 -
Grace Kim, J. Rosso (2010)
Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.The Journal of clinical and aesthetic dermatology, 3 1
-
Ö Kutlu (2020)
e13383Dermatol Ther, 33
-
K. Gananandan, B. Sacks, I. Ewing (2020)
Guttate psoriasis secondary to COVID-19BMJ Case Reports, 13
-
Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID- (2021)
//derma.de/corona/impfung-gegen-sars-cov-2/. Zugegriffen: 13. Dez. 2021 -
Ö. Elmas, Abdullah Demirbaş, Ömer Kutlu, F. Bağcıer, M. Metin, Kemal Özyurt, N. Akdeniz, M. Atasoy, Ü. Türsen, T. Lotti (2020)
Psoriasis and COVID‐19: A narrative review with treatment considerationsDermatologic Therapy, 33
-
S. Mahil, N. Dand, K. Mason, Zenas Yiu, T. Tsakok, F. Meynell, B. Coker, H. McAteer, L. Moorhead, T. Mackenzie, M. Rossi, R. Rivera, E. Mahé, A. Carugno, M. Magnano, G. Rech, Esther Balogh, S. Feldman, C. Cruz, S. Choon, L. Naldi, J. Lambert, P. Spuls, D. Jullien, H. Bachelez, D. McMahon, E. Freeman, P. Gisondi, L. Puig, R. Warren, P. Meglio, S. Langan, F. Capon, C. Griffiths, J. Barker, Catherine Smith, Aadarsh Mor, Aadarsh Shah, A. Barea, A. Romero-Maté, Alekya Singapore, A. Paolino, A. Mwale, A. Callaghan, Ana Martínez, A. DeCrescenzo, A. Pink, Ann‐Britt Jones, A. Sergeant, A. Essex, A. Bewley, A. Makrygeorgou, A. Huizen, B. Pérez-Suárez, Benhadou Farida, B. Claréus, Carla Prims, C. Davis, C. Quinlan, C. Maybury, Gonzalez Cesar, C. Barclay, C. Greco, D. Brassard, Dean Cummings, D. Kolli, V. Descamps, D. Genao, E. Carras, E. Hawryluk, E. Martínez-García, E. Kłujszo, E. Dwyer, E. Toni, E. Sonkoly, E. Loayza, E. Daudén, F. Valenzuela, G. Popov, G. King, Girard Celine, G. Aparicio, G. Johnston, Gustavo Cardozo, I. Pearson, I. Yanguas, J. Weisman, J. Carolan, J. Hughes, J. Ortiz-Salvador, J. Carrascosa, Jasmine Schwartz, K. Jackson, Kathryn Kerisit, Keith Wu, L. Asfour, Leontien Graaf, C. Lesort, L. Meuleman, L. Eidsmo, L. Skov, Lorraine Gribben, M. Rustin, M. Velasco, M. Panchal, M. Lakhan, M. Franco, M. Svensson, M. Vandaele, M. Marovt, O. Zargari, P. Caso, P. Varela, P. Jenkin, C. Phan, P. Hampton, P. Goldsmith, Rachel Bak, R. Speeckaert, R. Romiti, R. Woolf, Rogelio Mercado-Seda, R. Khatun, R. Čeović, R. Taberner, Russell Cohen, S. Stefanescu, Sarah Kirk, S. Reeken, S. Ayob, S. Pérez-Barrio, S. Piaserico, S. Hoey, T. Torres, T. Talme, Trupti Desai, A. Geest, Victoria King, V. Lernia, Zahira Koreja, Vito Hasab (2020)
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based studyThe Journal of Allergy and Clinical Immunology, 147
-
(2021)
SARSCoV-2 and guttate psoriasis: a case report and reviewof -
S Beissert T Buhl (2020)
COVID-19 und Auswirkungen auf dermatologische und allergologische ErkrankungenJ Dtsch Dermatol Ges, 18
-
A. Gravani, G. Gaitanis, A. Zioga, I. Bassukas (2014)
Synthetic antimalarial drugs and the triggering of psoriasis – do we need disease‐specific guidelines for the management of patients with psoriasis at risk of malaria?International Journal of Dermatology, 53
-
Ömer Kutlu, A. Metin (2020)
Dermatological diseases presented before COVID‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID‐19?Dermatologic Therapy, 33
-
S. Nasiri, F. Araghi, M. Tabary, M. Gheisari, Zahra Mahboubi-Fooladi, S. Dadkhahfar (2020)
A challenging case of psoriasis flare-up after COVID-19 infectionJournal of Dermatological Treatment, 31
-
A. Said, Stephanie Bock, Trim Lajqi, G. Müller, G. Weindl (2014)
Chloroquine Promotes IL-17 Production by CD4+ T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like CellsThe Journal of Immunology, 193
-
A. Polat, I. Topal, A. Karadağ, H. Aksoy, A. Aksu, E. Ozkur, T. Akbulut, F. Demir, B. Engin, T. Uzunçakmak, I. Altunay (2020)
The impact of COVID‐19 in patients with psoriasis: A multicenter study in IstanbulDermatologic Therapy, 34
-
(Wu JJ, Liu J, Thatiparthi A et al (2021) Association between systemic treatments and COVID-19 infection risk in patients with psoriasis. https://www.aad.org/member/meetings-education/aadvmx (Virtueller Kongress der American Academy of Dermatology, Late Breaker Session 24.04.2021). Zugegriffen: 22. Juni 2021)
Wu JJ, Liu J, Thatiparthi A et al (2021) Association between systemic treatments and COVID-19 infection risk in patients with psoriasis. https://www.aad.org/member/meetings-education/aadvmx (Virtueller Kongress der American Academy of Dermatology, Late Breaker Session 24.04.2021). Zugegriffen: 22. Juni 2021Wu JJ, Liu J, Thatiparthi A et al (2021) Association between systemic treatments and COVID-19 infection risk in patients with psoriasis. https://www.aad.org/member/meetings-education/aadvmx (Virtueller Kongress der American Academy of Dermatology, Late Breaker Session 24.04.2021). Zugegriffen: 22. Juni 2021, Wu JJ, Liu J, Thatiparthi A et al (2021) Association between systemic treatments and COVID-19 infection risk in patients with psoriasis. https://www.aad.org/member/meetings-education/aadvmx (Virtueller Kongress der American Academy of Dermatology, Late Breaker Session 24.04.2021). Zugegriffen: 22. Juni 2021
-
Maria Visser, D. Kell, E. Pretorius (2019)
Bacterial Dysbiosis and Translocation in Psoriasis VulgarisFrontiers in Cellular and Infection Microbiology, 9
-
T. Buhl, S. Beissert, E. Gaffal, M. Goebeler, M. Hertl, C. Mauch, K. Reich, E. Schmidt, M. Schön, M. Sticherling, C. Sunderkötter, C. Traidl‐Hoffmann, T. Werfel, Dagmar Wilsman‐Theis, M. Worm (2020)
COVID‐19 und Auswirkungen auf dermatologische und allergologische ErkrankungenJournal Der Deutschen Dermatologischen Gesellschaft, 18
-
A. Ebrahimi, B. Sayad, Z. Rahimi (2020)
COVID-19 and psoriasis: biologic treatment and challengesJournal of Dermatological Treatment, 33
-
M. Gianfrancesco, K. Hyrich, Sarah Al-Adely, L. Carmona, M. Danila, L. Gossec, Z. Izadi, L. Jacobsohn, P. Katz, S. Lawson-Tovey, E. Mateus, Stephanie Rush, G. Schmajuk, J. Simard, A. Strangfeld, L. Trupin, K. Wysham, S. Bhana, W. Costello, R. Grainger, J. Hausmann, J. Liew, E. Sirotich, P. Sufka, Z. Wallace, J. Yazdany, P. Machado, P. Robinson (2020)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registryAnnals of the Rheumatic Diseases
-
D. Samotij, Ewelina Gawron, J. Szczęch, Elżbieta Ostańska, A. Reich (2021)
Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID‐19: A Case Report of a Successful Treatment with Infliximab in Combination with AcitretinBiologics : Targets & Therapy, 15
-
M. Sachdeva, A. Mufti, K. Maliyar, Y. Lytvyn, J. Yeung (2020)
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatmentJournal of the American Academy of Dermatology, 83
-
(2021)
SARS - CoV - 2 and guttate psoriasis : a case report and reviewof literature -
(2020)
Metin A (2020) A case of exacerbation of psoriasisafteroseltamivirandhydroxychloroquine in a patient with COVID-19: Will cases of psoriasis -
( Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https://derma.de/corona/impfung-gegen-sars-cov-2/. Zugegriffen: 13. Dez. 2021)
Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https://derma.de/corona/impfung-gegen-sars-cov-2/. Zugegriffen: 13. Dez. 2021Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https://derma.de/corona/impfung-gegen-sars-cov-2/. Zugegriffen: 13. Dez. 2021, Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https://derma.de/corona/impfung-gegen-sars-cov-2/. Zugegriffen: 13. Dez. 2021
-
P. Amerio, F. Prignano, Federica Giuliani, G. Gualdi (2020)
COVID‐19 and psoriasis: Should we fear for patients treated with biologics?Dermatologic Therapy, 33
-
Eleanor Mallon, Christopher Bunker (2000)
HIV-associated psoriasis.AIDS patient care and STDs, 14 5
-
(2017)
Drug-induced psoriasis: clinicalperspectives.Psoriasis7:87–94 -
L. Wijs, M. Joustra, J. Olydam, Tamar Nijsten, D. Hijnen (2020)
COVID‐19 in patients with cutaneous immune‐mediated diseases in The Netherlands: real‐world observational dataJournal of the European Academy of Dermatology and Venereology, 35
-
biologic treatment and challenges -
COVID - 19 and psoriasis : Should we fear for patients treatedwithbiologics ? -
(2021)
Psoriasis exacerbationafterCOVID-19vaccination: a reportof 14 cases fromasingle centre -
D. Balak, E. Hajdarbegovic (2017)
Drug-induced psoriasis: clinical perspectivesPsoriasis (Auckland, N.Z.), 7
-
Adriana Rendon, K. Schäkel (2019)
Psoriasis Pathogenesis and TreatmentInternational Journal of Molecular Sciences, 20
-
D. Jamiolkowski, B. Mühleisen, S. Müller, A. Navarini, A. Tzankov, E. Roider (2020)
SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case reportLancet (London, England), 396
-
D. Ragab, Haitham Eldin, M. Taeimah, R. Khattab, R. Salem (2020)
The COVID-19 Cytokine Storm; What We Know So FarFrontiers in Immunology, 11
-
ÖF Elmas (2020)
e13858Dermatol Ther, 33
-
A Elrazi (2021)
e04568Clin Case Rep, 9
-
(2000)
HIV-associated psoriasis.AIDSPatientCareSTDS14:239–246 -
(2020)
A case of exacerbation of psoriasisafteroseltamivirandhydroxychloroquine in a patient with COVID - 19 : Will cases of psoriasis increaseafterCOVID - 19 pandemic ? -
(2021)
Association betweensystemic treatmentsandCOVID-19 infection risk in patients with psoriasis -
( Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https://dgrh.de/Start/Wissenschaft/Forschung/COVID-19.html. Zugegriffen: 13. Dez. 2021)
Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https://dgrh.de/Start/Wissenschaft/Forschung/COVID-19.html. Zugegriffen: 13. Dez. 2021Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https://dgrh.de/Start/Wissenschaft/Forschung/COVID-19.html. Zugegriffen: 13. Dez. 2021, Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https://dgrh.de/Start/Wissenschaft/Forschung/COVID-19.html. Zugegriffen: 13. Dez. 2021
-
E. Sotiriou, A. Tsentemeidou, K. Bakirtzi, A. Lallas, D. Ioannides, E. Vakirlis (2021)
Psoriasis exacerbation after COVID‐19 vaccination: a report of 14 cases from a single centreJournal of the European Academy of Dermatology and Venereology, 35
-
T Buhl (2020)
815J Dtsch Dermatol Ges, 18
-
(2020)
COVID19 and psoriasis: Should we fear for patients -
(2020)
Psoriasis flare after influenza vaccination in Covid-19 era: a report of four cases froma single center.DermatolTher34(1):e14684 -
LEM de Wijs (2021)
e173J Eur Acad Dermatol Venereol, 35
-
Psoriasis pathogenesis andtreatment -
M. Buszko, A. Nita-lazar, Jung-Hyun Park, P. Schwartzberg, D. Verthelyi, H. Young, A. Rosenberg (2021)
Lessons learned: new insights on the role of cytokines in COVID-19Nature Immunology, 22
- Publisher
- Springer Journals
- Copyright
- 2022 The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature
- ISSN
- 1866-2250
- eISSN
- 2192-6484
- DOI
- 10.1007/s12326-022-00506-5
- Publisher site
- See Article on Publisher Site
Abstract
Zusammenfassung Wir präsentieren einen klinischen Fall eines Patienten mit akut exazerbierter erythrodermer Plaquepsoriasis nach einer symptomatischen Infektion mit SARS-CoV‑2. Es sind bereits unterschiedliche Faktoren bekannt, die zu einer Exazerbation der Psoriasis führen können wie Medikamente oder Infektionen mit z. B. Streptokokken. Ein Zusammenhang zwischen Psoriasis und einer Infektion mit dem neuartigen Coronavirus SARS-CoV‑2 wurde v. a. in Fallberichten beschrieben, in denen eine medikamentöse Behandlung mit z. B. Hydroxychloroquin erfolgt war, ein bekannter Trigger der Psoriasis. In der Folge gab es auch einzelne Beschreibungen einer Exazerbation nach COVID-19 ohne medikamentösen Trigger, teils auch als pustulöse Psoriasisform. Unser Artikel zeigt erstmals einen Fall einer Psoriasiserythrodermie getriggert durch eine COVID-19-Erkrankung ohne offensichtlich zusätzlich medikamentösen Auslöser.
Journal
hautnah – Springer Journals
Published: May 1, 2022
Keywords: dermatology; medicine/public health, general